vs
Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Eastern Bankshares, Inc. is the larger business by last-quarter revenue ($295.9M vs $151.7M, roughly 2.0× Nutex Health, Inc.). Eastern Bankshares, Inc. runs the higher net margin — 22.1% vs 7.8%, a 14.3% gap on every dollar of revenue. On growth, Eastern Bankshares, Inc. posted the faster year-over-year revenue change (710.6% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 38.6%).
Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
EBC vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $151.7M |
| Net Profit | $65.3M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 22.1% | 7.8% |
| Revenue YoY | 710.6% | -41.1% |
| Net Profit YoY | -34.4% | -80.8% |
| EPS (diluted) | $0.29 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.9M | — | ||
| Q4 25 | $37.5M | $151.7M | ||
| Q3 25 | $241.5M | $267.8M | ||
| Q2 25 | $244.9M | $244.0M | ||
| Q1 25 | $31.1M | $211.8M | ||
| Q4 24 | $216.5M | $257.6M | ||
| Q3 24 | $203.4M | $78.8M | ||
| Q2 24 | $154.0M | $76.1M |
| Q1 26 | $65.3M | — | ||
| Q4 25 | $99.5M | $11.8M | ||
| Q3 25 | $106.1M | $55.4M | ||
| Q2 25 | $100.2M | $-17.7M | ||
| Q1 25 | $-217.7M | $21.2M | ||
| Q4 24 | $60.8M | $61.6M | ||
| Q3 24 | $-6.2M | $-8.8M | ||
| Q2 24 | $26.3M | $-364.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 20.4% | ||
| Q3 25 | 38.9% | 48.7% | ||
| Q2 25 | 41.0% | 13.8% | ||
| Q1 25 | -590.9% | 38.1% | ||
| Q4 24 | 33.3% | 44.4% | ||
| Q3 24 | -1.6% | 12.3% | ||
| Q2 24 | 24.7% | 7.0% |
| Q1 26 | 22.1% | — | ||
| Q4 25 | 265.6% | 7.8% | ||
| Q3 25 | 44.0% | 20.7% | ||
| Q2 25 | 40.9% | -7.3% | ||
| Q1 25 | -699.2% | 10.0% | ||
| Q4 24 | 28.1% | 23.9% | ||
| Q3 24 | -3.0% | -11.2% | ||
| Q2 24 | 17.1% | -0.5% |
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.48 | $2.34 | ||
| Q3 25 | $0.53 | $7.76 | ||
| Q2 25 | $0.50 | $-2.95 | ||
| Q1 25 | $-1.08 | $3.33 | ||
| Q4 24 | $0.29 | $11.56 | ||
| Q3 24 | $-0.03 | $-1.72 | ||
| Q2 24 | $0.16 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $551.7M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.3B | $329.4M |
| Total Assets | $30.6B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $551.7M | — | ||
| Q4 25 | $507.6M | $185.6M | ||
| Q3 25 | $703.4M | $166.0M | ||
| Q2 25 | $948.3M | $96.7M | ||
| Q1 25 | $609.0M | $84.7M | ||
| Q4 24 | $1.9B | $40.6M | ||
| Q3 24 | $1.7B | $46.9M | ||
| Q2 24 | $1.4B | $40.8M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $329.4M | ||
| Q3 25 | $3.8B | $317.2M | ||
| Q2 25 | $3.7B | $235.3M | ||
| Q1 25 | $3.6B | $176.9M | ||
| Q4 24 | $3.6B | $132.4M | ||
| Q3 24 | $3.7B | $60.4M | ||
| Q2 24 | $3.0B | $62.7M |
| Q1 26 | $30.6B | — | ||
| Q4 25 | $30.6B | $918.5M | ||
| Q3 25 | $25.5B | $964.5M | ||
| Q2 25 | $25.5B | $841.0M | ||
| Q1 25 | $25.0B | $761.9M | ||
| Q4 24 | $25.6B | $655.3M | ||
| Q3 24 | $25.5B | $438.5M | ||
| Q2 24 | $21.0B | $422.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $432.4M | $70.4M | ||
| Q3 25 | $157.1M | $99.5M | ||
| Q2 25 | $123.9M | $27.3M | ||
| Q1 25 | $47.3M | $51.0M | ||
| Q4 24 | $283.8M | $54.0K | ||
| Q3 24 | $108.3M | $6.8M | ||
| Q2 24 | $54.3M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.35× | 5.95× | ||
| Q3 25 | 1.48× | 1.80× | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | 4.67× | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EBC
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
